| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.00035 | 1 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.00033 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.00035 | 1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0003 | 1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00027 | 1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.0025 | 1 |